Core Historical Income Statement

CLB Stock

USD 16.99 0.30 1.80%

Historical analysis of Core Laboratories income statement accounts such as Interest Expense of 10.1 M, Selling General Administrative of 34.3 M or Total Revenue of 619.3 M can show how well Core Laboratories NV performed in making a profits. Evaluating Core Laboratories income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Core Laboratories's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Core Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Core Laboratories is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Core Income Statement Analysis

Core Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Core Laboratories shareholders. The income statement also shows Core investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Core Laboratories Income Statement Chart

Core Laboratories NV Income Statement is one of the three primary financial statements used for reporting Core's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Core Laboratories revenue and expense. Core Laboratories Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At present, Core Laboratories' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 619.3 M, whereas Interest Expense is forecasted to decline to about 10.1 M.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts Core Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Core Laboratories NV minus its cost of goods sold. It is profit before Core Laboratories operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Core Laboratories. It is also known as Core Laboratories overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Core Laboratories' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Gross Profit	83.8M	78.9M	94.0M	171.1M
Total Revenue	470.3M	489.7M	509.8M	619.3M

Gross Profit Total Revenue

Core Laboratories income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Minority Interest	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Discontinued Operations	Net Interest Income	Extraordinary Items	Reconciled Depreciation	Non Recurring
Depreciation And Amortization		0.65	0.78	0.8	0.65	0.88	0.57	0.56	0.6	0.87	0.77	0.51	0.01	0.51	0.45	0.1	0.08	0.22	0.85	0.03	0.12	0.08	-0.01	0.05	0.32	0.1
Interest Expense	0.65		0.73	0.34	0.11	0.53	0.03	0.03	0.06	0.51	0.64	-0.08	-0.36	-0.05	-0.12	-0.05	0.2	-0.38	0.82	-0.53	0.25	0.37	-0.47	0.38	-0.27	-0.05
Selling General Administrative	0.78	0.73		0.67	0.48	0.8	0.42	0.42	0.45	0.78	0.88	0.41	0.14	0.42	0.34	0.13	0.45	0.12	0.85	-0.04	0.08	0.21	-0.04	0.2	0.05	0.13
Total Revenue	0.8	0.34	0.67		0.96	0.97	0.93	0.92	0.94	0.98	0.72	0.89	0.23	0.87	0.84	0.13	0.04	0.66	0.65	0.39	0.18	-0.08	0.07	-0.11	0.42	0.13
Gross Profit	0.65	0.11	0.48	0.96		0.88	0.98	0.98	0.98	0.89	0.58	0.95	0.28	0.92	0.92	0.14	-0.01	0.79	0.44	0.57	0.18	-0.19	0.13	-0.23	0.52	0.14
Other Operating Expenses	0.88	0.53	0.8	0.97	0.88		0.82	0.82	0.84	1.0	0.82	0.78	0.18	0.78	0.72	0.11	0.09	0.5	0.8	0.23	0.16	0.03	0.02	0.0	0.31	0.11
Operating Income	0.57	0.03	0.42	0.93	0.98	0.82		1.0	1.0	0.84	0.48	0.96	0.28	0.93	0.95	0.29	-0.03	0.84	0.39	0.61	0.23	-0.21	0.21	-0.26	0.58	0.29
Ebit	0.56	0.03	0.42	0.92	0.98	0.82	1.0		1.0	0.84	0.48	0.96	0.28	0.93	0.95	0.29	-0.03	0.84	0.39	0.61	0.23	-0.21	0.21	-0.25	0.58	0.29
Ebitda	0.6	0.06	0.45	0.94	0.98	0.84	1.0	1.0		0.86	0.5	0.96	0.27	0.93	0.95	0.29	-0.03	0.83	0.42	0.59	0.24	-0.2	0.21	-0.24	0.58	0.29
Cost Of Revenue	0.87	0.51	0.78	0.98	0.89	1.0	0.84	0.84	0.86		0.79	0.79	0.18	0.79	0.73	0.12	0.07	0.52	0.78	0.24	0.16	0.02	0.03	-0.01	0.32	0.12
Total Operating Expenses	0.77	0.64	0.88	0.72	0.58	0.82	0.48	0.48	0.5	0.79		0.48	0.19	0.49	0.39	0.0	0.39	0.2	0.79	0.07	0.04	0.13	-0.04	0.12	0.1	0.0
Income Before Tax	0.51	-0.08	0.41	0.89	0.95	0.78	0.96	0.96	0.96	0.79	0.48		0.53	0.99	0.92	0.24	-0.01	0.92	0.31	0.64	0.09	-0.19	0.32	-0.22	0.57	0.24
Total Other Income Expense Net	0.01	-0.36	0.14	0.23	0.28	0.18	0.28	0.28	0.27	0.18	0.19	0.53		0.58	0.29	-0.02	0.12	0.62	-0.12	0.35	-0.39	-0.01	0.46	0.0	0.21	-0.02
Net Income	0.51	-0.05	0.42	0.87	0.92	0.78	0.93	0.93	0.93	0.79	0.49	0.99	0.58		0.86	0.21	-0.02	0.93	0.3	0.57	0.1	-0.08	0.27	-0.12	0.56	0.21
Income Tax Expense	0.45	-0.12	0.34	0.84	0.92	0.72	0.95	0.95	0.95	0.73	0.39	0.92	0.29	0.86		0.29	0.0	0.81	0.31	0.77	0.07	-0.46	0.39	-0.49	0.52	0.29
Selling And Marketing Expenses	0.1	-0.05	0.13	0.13	0.14	0.11	0.29	0.29	0.29	0.12	0.0	0.24	-0.02	0.21	0.29		0.11	0.31	0.17	0.26	0.5	0.07	0.41	0.01	0.63	1.0
Minority Interest	0.08	0.2	0.45	0.04	-0.01	0.09	-0.03	-0.03	-0.03	0.07	0.39	-0.01	0.12	-0.02	0.0	0.11		-0.04	0.1	0.12	0.25	-0.01	-0.22	-0.02	0.08	0.11
Net Income From Continuing Ops	0.22	-0.38	0.12	0.66	0.79	0.5	0.84	0.84	0.83	0.52	0.2	0.92	0.62	0.93	0.81	0.31	-0.04		-0.05	0.7	0.15	-0.14	0.35	-0.19	0.68	0.31
Non Operating Income Net Other	0.85	0.82	0.85	0.65	0.44	0.8	0.39	0.39	0.42	0.78	0.79	0.31	-0.12	0.3	0.31	0.17	0.1	-0.05		-0.2	0.07	0.15	0.01	0.15	-0.03	0.17
Tax Provision	0.03	-0.53	-0.04	0.39	0.57	0.23	0.61	0.61	0.59	0.24	0.07	0.64	0.35	0.57	0.77	0.26	0.12	0.7	-0.2		-0.07	-0.69	0.54	-0.73	0.56	0.26
Interest Income	0.12	0.25	0.08	0.18	0.18	0.16	0.23	0.23	0.24	0.16	0.04	0.09	-0.39	0.1	0.07	0.5	0.25	0.15	0.07	-0.07		0.37	-0.54	0.3	0.47	0.5
Discontinued Operations	0.08	0.37	0.21	-0.08	-0.19	0.03	-0.21	-0.21	-0.2	0.02	0.13	-0.19	-0.01	-0.08	-0.46	0.07	-0.01	-0.14	0.15	-0.69	0.37		-0.43	1.0	-0.03	0.07
Net Interest Income	-0.01	-0.47	-0.04	0.07	0.13	0.02	0.21	0.21	0.21	0.03	-0.04	0.32	0.46	0.27	0.39	0.41	-0.22	0.35	0.01	0.54	-0.54	-0.43		-0.43	0.26	0.41
Extraordinary Items	0.05	0.38	0.2	-0.11	-0.23	0.0	-0.26	-0.25	-0.24	-0.01	0.12	-0.22	0.0	-0.12	-0.49	0.01	-0.02	-0.19	0.15	-0.73	0.3	1.0	-0.43		-0.11	0.01
Reconciled Depreciation	0.32	-0.27	0.05	0.42	0.52	0.31	0.58	0.58	0.58	0.32	0.1	0.57	0.21	0.56	0.52	0.63	0.08	0.68	-0.03	0.56	0.47	-0.03	0.26	-0.11		0.63
Non Recurring	0.1	-0.05	0.13	0.13	0.14	0.11	0.29	0.29	0.29	0.12	0.0	0.24	-0.02	0.21	0.29	1.0	0.11	0.31	0.17	0.26	0.5	0.07	0.41	0.01	0.63

Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	22.6M	20.9M	18.5M	17.2M	15.8M	21.8M
Interest Expense	14.7M	14.4M	9.2M	11.6M	13.4M	10.1M
Selling General Administrative	48.0M	34.0M	44.2M	38.1M	43.8M	34.3M
Total Revenue	668.2M	487.3M	470.3M	489.7M	509.8M	619.3M
Gross Profit	150.0M	91.6M	83.8M	78.9M	94.0M	171.1M
Other Operating Expenses	566.2M	429.7M	430.6M	448.2M	456.0M	494.0M
Operating Income	96.7M	55.8M	45.3M	41.5M	53.8M	51.1M
Ebit	96.7M	55.8M	45.3M	41.5M	53.8M	51.1M
Ebitda	119.3M	76.6M	63.8M	58.7M	69.6M	66.1M
Cost Of Revenue	518.2M	395.6M	386.4M	410.8M	415.7M	448.2M
Total Operating Expenses	48.0M	34.0M	44.2M	37.4M	40.3M	45.7M
Income Before Tax	82.0M	(91.2M)	36.1M	30.0M	40.8M	38.8M
Total Other Income Expense Net	(14.7M)	(147.0M)	(9.2M)	(11.6M)	(13.0M)	(13.6M)
Net Income	102.0M	(97.1M)	19.7M	19.5M	36.7M	34.8M
Income Tax Expense	(12.3M)	5.9M	15.9M	10.3M	4.2M	4.0M
Net Income Applicable To Common Shares	102.0M	(97.6M)	19.7M	19.5M	22.4M	21.3M
Minority Interest	134K	140K	(492K)	(205K)	(235.8K)	(224.0K)
Net Income From Continuing Ops	94.3M	(97.1M)	20.2M	19.7M	17.7M	16.8M
Tax Provision	(12.3M)	5.9M	15.9M	10.3M	9.3M	10.8M
Interest Income	14.7M	14.4M	9.2M	11.6M	10.4M	9.8M
Discontinued Operations	2.1M	(58K)	7.8M	(424K)	(487.6K)	(463.2K)
Net Interest Income	(14.7M)	(14.4M)	(9.2M)	(11.6M)	(13.3M)	(14.0M)
Reconciled Depreciation	22.6M	20.9M	18.5M	17.2M	15.4M	17.0M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Core Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Core Laboratories' short interest history, or implied volatility extrapolated from Core Laboratories options trading.

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Stock

0.89	NR	Newpark Resources Financial Report 7th of May 2024	Pair Corr
0.72	TS	Tenaris SA ADR Earnings Call This Week	Pair Corr

Moving against Core Stock

0.49

NOA

North American Const Earnings Call This Week

Pair Corr

The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.

The correlation of Core Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:

How To Invest In Core

Details

Is Core Stock a good investment?

Details

What is Core Laboratories' Net Worth?

Details

Largest Oil & Gas Equipment & Services Companies

View

Largest Energy Companies

View

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.

	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	AI Investment Finder Use AI to screen and filter profitable investment opportunities

Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.72)

Dividend Share

0.04

Earnings Share

0.51

Revenue Per Share

10.92

Quarterly Revenue Growth

0.005

The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Historical Income Statement

About Core Income Statement Analysis

Core Laboratories Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Core Laboratories income statement Correlations

Core Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Core Laboratories income statement Accounts

Pair Trading with Core Laboratories

Moving together with Core Stock

Moving against Core Stock

Complementary Tools for Core Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Non Recurring	+ 1.0	Selling And Marketing Expenses
Extraordinary Items	+ 1.0	Discontinued Operations

Extraordinary Items	- 0.73	Tax Provision
Discontinued Operations	- 0.69	Tax Provision
Net Interest Income	- 0.54	Interest Income
Tax Provision	- 0.53	Interest Expense
Extraordinary Items	- 0.49	Income Tax Expense
Net Interest Income	- 0.47	Interest Expense